Publications found:
1,071
Sort by:
Global Lung Cancer Therapeutics Market - 2025 -2033
US$ 4,350.00
Global Lung Cancer Therapeutics Market: Industry Outlook The global lung cancer therapeutics market reached US$ 24.00 Billion in 2023, with a rise of US$ 25.92 Billion in 2024 and is expected to reach...
October 2025
180 pages
Global Oncolytic Viral Therapy Market - 2025 -2033
US$ 4,350.00
Oncolytic Viral Therapy Market Size Oncolytic Viral Therapy Market Size reached US$ 24.48 Million in 2024 and is expected to reach US$ 164.51 Million by 2033, growing at a CAGR of 23.8% during the for...
October 2025
180 pages
Global Thymus Cancer Market - 2025 -2033
US$ 4,350.00
Thymus Cancer Market Size In 2023, the global thymus cancer was valued at US$ 4.82 Billion. The global thymus cancer market size reached US$ 5.03 Billion in 2024 and is expected to reach US$ 7.80 Bill...
October 2025
180 pages
Global Triple Negative Breast Cancer Market - 2025 -2033
US$ 4,350.00
Triple Negative Breast Cancer Treatment Market Size and Trends The global triple negative breast cancer Treatment Market reached US$ 0.95billion in 2023, with a rise to US$ 1.00billion in 2024, and is...
October 2025
180 pages
India Prostate Cancer Market - 2025 -2033
US$ 3,175.00
India Prostate Cancer Treatment Market: Industry Outlook The India Prostate Cancer Treatment market reached US$ 12,146.00 Million in 2023, with a rise of US$ 13,220.00 Million in 2024 and is expected...
October 2025
180 pages
Global Fluorouracil Tablets Market Growth 2025-2031
US$ 3,660.00
The global Fluorouracil Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Fluor...
September 2025
102 pages
Global EGFR Inhibitor Market Growth 2025-2031
US$ 3,660.00
The global EGFR Inhibitor market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for EGFR Inhibi...
September 2025
123 pages
Global Fulvestrant Injection Market Growth 2025-2031
US$ 3,660.00
The global Fulvestrant Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Fulv...
September 2025
106 pages
Global Gefitinib Tablets Market Growth 2025-2031
US$ 3,660.00
The global Gefitinib Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Gefitini...
September 2025
113 pages
Global Carmustine Injection Market Growth 2025-2031
US$ 3,660.00
The global Carmustine Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Carmu...
September 2025
88 pages
Global CTLA-4 Inhibitors Market Growth 2025-2031
US$ 3,660.00
The global CTLA-4 Inhibitors market size is predicted to grow from US$ 1297 million in 2025 to US$ 2319 million in 2031; it is expected to grow at a CAGR of 10.2% from 2025 to 2031. CTLA-4, cytotoxic...
September 2025
93 pages
Liposomal Doxorubicin Market Size, Share & Trends Analysis Report By Product (Doxil/Caelyx, Lipodox, Myocet), By Application (Multiple Myeloma, Ovarian Cancer, Breast Cancer, AIDS-related Kaposi’s Sarcoma), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Liposomal Doxorubicin Market The global liposomal doxorubicin market size was estimated at USD 1.31 billion in 2024 and is projected to reach USD 2.38 billion by 2033, growing at a CAGR of 7.04% from...
September 2025
125 pages
NUT Midline Carcinoma Treatment Market Size, Share & Trends Analysis Report By Treatment (Chemotherapy, Targeted Therapy), By Route Of Administration (Oral, IV), By End Use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
NUT Midline Carcinoma Treatment Market The global NUT midline carcinoma treatment market size was estimated at USD 21.44 billion in 2024 and is projected to reach USD 69.53 billion by 2033, growing at...
September 2025
120 pages
Low-Grade Glioma Market - 2024-2033
US$ 2,999.00
The Low-Grade Glioma Market was valued at US$ 1.24Billion in 2024 and is anticipated to reach US$ 1.87Billion by 2033, at a CAGR of 0.047 from 2026 to 2032. The report delivers in-depth insights into...
September 2025
217 pages
Methotrexate Injection Market 2026
US$ 2,999.00
The Methotrexate Injection Market was valued at in and is anticipated to reach by , at a CAGR of 0.05 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regio...
September 2025
218 pages
Triple Negative Breast Cancer Treatment Market - 2023-2033
US$ 2,999.00
The Triple Negative Breast Cancer Treatment Market was valued at US$ 0.95billion in 2023 and is anticipated to reach US$ 1.66billion by 2033, at a CAGR of 0.066 from 2026 to 2032. The report delivers...
September 2025
218 pages
Acral Lentiginous Melanoma Treatment Market 2026
US$ 2,999.00
The Acral Lentiginous Melanoma Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.03 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, i...
September 2025
207 pages
Oncology Drugs Market Forecasts to 2032 – Global Analysis By Drug Class (Cytotoxic Drugs, Targeted Therapy Drugs, Hormonal Therapy Drugs, Immunotherapy Drugs, and Other Drug Classes), Therapy Type, Cancer Type, Dosage Form, Distribution Channel, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Oncology Drugs Market is accounted for $258.98 billion in 2025 and is expected to reach $620.70 billion by 2032 growing at a CAGR of 13.3% during the forecast...
September 2025
200 pages
Global Liver Cancer Therapeutics Market - 2023-2033
US$ 2,999.00
The Global Liver Cancer Therapeutics Market was valued at US$ 2.92billion in 2023 and is anticipated to reach US$ 13.16billion by 2033, at a CAGR of 0.165 from 2026 to 2032. The report delivers in-dep...
September 2025
200 pages
Skin Cancer Market - 2024-2033
US$ 2,999.00
The Skin Cancer Market was valued at US$ 10.61 Billion in 2024 and is anticipated to reach US$ 20.48 Billion by 2033, at a CAGR of 0.076 from 2026 to 2032. The report delivers in-depth insights into k...
September 2025
223 pages
AI Tumor Evolution Maps Market Forecasts to 2032 – Global Analysis By Cancer Type (Brain Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Pancreatic Cancer, Hematologic Malignancies, Rare & Pediatric Cancers and Other Cancer Types), Technology, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global AI Tumor Evolution Maps Market is accounted for $196.03 million in 2025 and is expected to reach $1390.77 million by 2032 growing at a CAGR of 32.3% during the...
September 2025
200 pages
Radioligand Therapy (RLT) Market by Product (Lutetium-177 Vipivotide Tetraxetan, (Lu-177)- PNT2002, Radium-223 dichloride), Target (PSMA, SSTR, Bone Metastases), Indication (Prostate Cancer, Neuroendocrine Tumors (NETS), SCLC) - Global Forecast to 2035
US$ 4,950.00
The global radioligand therapy market is projected to reach USD 10.91 billion by 2035 from an estimated USD 3.15 billion in 2025, at a CAGR of 13.2% during the forecast period. The growth of the radio...
September 2025
313 pages
Secondary Myelofibrosis Market 2026
US$ 2,999.00
The Secondary Myelofibrosis Market was valued at in and is anticipated to reach by , at a CAGR of 0.06 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regi...
September 2025
220 pages
Targeted Alpha Therapies for Cancer Treatment: Global Market
US$ 2,950.00
Report The report provides an overview of the global market for targeted alpha therapies (TAT) for cancer and analyzes market trends. It includes global revenue ($ million) for the base year data 2024...
September 2025
81 pages
Breast Cancer Therapeutics Market - 2024-2033
US$ 2,999.00
The Breast Cancer Therapeutics Market was valued at US$ 37.75 Billion in 2024 and is anticipated to reach US$ 72.05 Billion by 2033, at a CAGR of 0.094 from 2026 to 2032. The report delivers in-depth...
September 2025
217 pages
NUT Midline Carcinoma Treatment Market Forecasts to 2032 – Global Analysis By Treatment Type (Chemotherapy, Targeted Therapy, Radiation Therapy, Immunotherapy, and Surgery), Route of Administration, Technology, Drug Class, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global NUT Midline Carcinoma Treatment Market is accounted for $24.99 billion in 2025 and is expected to reach $73.25 billion by 2032 growing at a CAGR of 16.6% durin...
September 2025
200 pages
Skin Cancer Treatment Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Melanoma and Non-Melanoma); Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Radiation Therapy, and Others); End User (Hospitals, Dermatology Clinics, Diagnostic and Cancer Care Centers, and Others); and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
US$ 4,450.00
The skin cancer treatment market size is projected to rise from US$11.79 billion in 2024 to reach US$19.53 billion by 2031. The market is expected to register a CAGR of 7.57% from 2025 to 2031. Major...
September 2025
241 pages
Cancer Immunotherapy Market - 2024-2033
US$ 2,999.00
The Cancer Immunotherapy Market was valued at US$ 137.70 billion in 2024 and is anticipated to reach US$ 261.74 billion by 2033, at a CAGR of 0.079 from 2026 to 2032. The report delivers in-depth insi...
September 2025
207 pages
Diffuse Large B-cell Lymphoma Therapeutics Market - 2021
US$ 2,999.00
The Diffuse Large B-cell Lymphoma Therapeutics Market was valued at USD 4,107.50 million in 2021 and is anticipated to reach by , at a CAGR of 0.075 from 2026 to 2032. The report delivers in-depth ins...
September 2025
217 pages
Global Cancer/Tumor Profiling Market Size study & Forecast, by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Other Cancer), Biomarker Type (Genomic Biomarker and Protein Biomarker), Technology, Technique, Application and Regional Forecasts 2025-2035
US$ 3,750.00
... – 2019 to 2026 Target Audience of the Global Cancer/Tumor Profiling Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value ...
September 2025
285 pages
Acute Myeloid Leukemia Therapeutics Market Report by Treatment Type (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-Metabolites, Tyrosine Kinase Inhibitors, and Others), Drug Type (Small Molecule Drugs, Biopharmaceuticals), Route of Administration (Oral, Injectables), and Region 2025-2033
US$ 3,999.00
The global acute myeloid leukemia therapeutics market size reached USD 1,343.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 3,461.4 Million by 2033, exhibiting a growt...
September 2025
144 pages
Hematologic Malignancies Market Report by Type (Leukemia, Lymphoma, Multiple Myeloma, and Others), Therapy (Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, and Others), End User (Hospitals, Diagnostics Centers, Research Centers, and Others), and Region 2025-2033
US$ 3,999.00
The global hematologic malignancies market size reached USD 65.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 129.5 Billion by 2033, exhibiting a growth rate (CAGR) of...
September 2025
143 pages
Lymphoma Treatment Market Report by Type (Hodgkin Lymphoma, Non-Hodgkin Lymphoma), Test Type (Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Biologic Therapy, and Others), Drug (Adcetris, Rituxan, Opdivo, Imbruvica, Keytruda, Revlimid, and Others), and Region 2025-2033
US$ 3,999.00
The global lymphoma treatment market size reached USD 14.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 27.4 Billion by 2033, exhibiting a growth rate (CAGR) of 7.13%...
September 2025
139 pages
